-
IMPORTANT: In the next few weeks, we will be upgrading the message board software. We expect minimal downtime during the upgrade, and we will attempt to complete this during low-traffic hours. We will post an exact time several days ahead of the switch.Dismiss Notice
In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to reminisce or reconnect, as they will remain open for posting. We may also remove some board threads that have been inactive for several years.
Recent Posts
-
-
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
via GSK (GSK.L) has been sued by an independent Connecticut laboratory that accused the drugmaker of defrauding the U.S. government and taxpayers by concealing cancer risks in Zantac, once a blockbuster heartburn drug. article source
-
GLP-1 Receptor Agonist Market to Reach $125B by 2033: GlobalData
via The market for GLP-1 receptor agonists is growing at an “unprecedented” rate and by 2033 will be worth more than $125 billion, according to a Friday report from analytics firm GlobalData. GLP-1 analogs will become a dominant force in the...
-
Forbion-backed biotech Progentos debuts with $65M for MS drug
via Progentos says the money will go toward expanding its pipeline and pushing an experimental treatment for multiple sclerosis through “proof of concept” testing. article source
-
How Merck for Mothers reached 30M women through maternal health programs
via Merck announced that the $650 million effort eclipsed its benchmark goal and has reached more than 30 million women worldwide through its various programs. article source
-
3rd time's the charm? PTC will get another chance to keep Translarna's European...
via Four months after Europe's drug reviewers doubled down and recommended the withdrawal of PTC Therapeutics' Translarna for lack of efficacy, the drug's regulatory odyssey is taking yet another turn. article source
-
Dez handles the apology.
Would a Stalin reference have been better? He murdered more people than Hitler.
- + Show More
-
General Discussion
Discussion boards of general interest for those in the pharma, biotech, medical device, and related industries
-
Pharma/Biotech Companies
Anonymous discussion boards for pharmaceutical and biotech companies
-
Regional Discussion and Job Opportunities
Discussion and job opportunities by region
-
Lost Civilizations
Anonymous discussion boards for pharma/medical companies that no longer exist due to acquisition or other factors
-
Laboratory/Diagnostic Sales
Anonymous discussion boards for lab sales/diagnostics companies
-
Animal Health Sales
Anonymous discussion boards for animal health companies
-
Medical Equipment/Device Sales
Anonymous discussion boards for medical equipment/device companies
-
Pharmacies
Anonymous boards for pharmacy employees
-
PBMs
Anonymous discussion boards for PBMs
-
Pharma/Healthcare Marketing Agencies
Anonymous discussion boards for pharma/healthcare marketing agencies
-
Dental Reps
Anonymous discussion boards for dental health companies
-
Managed Care Specialists
Anonymous discussion boards for managed care specialists
-
Pharma IT
Anonymous discussion boards for pharma IT employees